Who Owns INBX?

Inhibrx Biosciences, Inc. — Institutional Ownership & 13F Holdings

$128.87

-0.19 (-0.15%)

Market Cap

$1.8B

Shares Outstanding

14,607,036

Institutional Holders

93

Total Inst. Value

$145.5M

% of Float Held

106.4%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VIKING GLOBAL INVESTORS LP$25.0M1,787,705
2Sanofi$16.2M1,157,926
3PERCEPTIVE ADVISORS LLC$14.9M1,064,026
4HighTower Advisors, LLC$12.2M871,754
5BlackRock, Inc.$11.6M832,732
6Sofinnova Investments, Inc.$9.8M697,916
7VANGUARD GROUP INC$8.2M588,323
8PFM Health Sciences, LP$6.1M439,283
9Woodline Partners LP$5.0M358,436
10Slotnik Capital, LLC$4.0M286,962

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold INBX?

As of Q1 2025, 93 institutional investors report holding INBX (Inhibrx Biosciences, Inc.) in their 13F filings.

What percentage of Inhibrx Biosciences, Inc. is owned by institutions?

Institutional investors hold approximately 106.4% of Inhibrx Biosciences, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most INBX?

The largest institutional holder of INBX is VIKING GLOBAL INVESTORS LP with $25.0M in shares.

Are institutions buying or selling INBX?

This quarter, 12 institutions opened new positions in INBX and 19 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.